Related Experiment Video
Updated: Apr 11, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
FOXK2 gene expression in cancer: Potential regulatory mechanisms and clinical implications
Renata Ivo Vasconcelos1, Luciana da Torre Carneiro1, Raquel Ciuvalschi Maia2
1Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro (UFRJ), Avenida Carlos Chagas Filho, 373, 2° andar, H2-003, Cidade Universitária, Rio de Janeiro 21 941 599, Brazil.
Abstract:
FOXK2 is a transcription factor known to regulate a wide range of biological processes that are critically involved in determining cell fate. Increasing evidence shows aberrant FOXK2 expression in some tumors, with crucial biological and clinical impacts. It is important to note that the molecular mechanisms contributing to FOXK2 gene deregulation are poorly understood for most cancers. In this review, we systematically describe the FOXK2 gene expression profile across distinct tumor types and discuss its potential utility as a prognostic and diagnostic molecular marker. Notably, we explore emerging mechanisms accounting for FOXK2 deregulation, focusing on genetic and transcriptional modifications, such as gene methylation, mutation and copy number variations.
Insights
Aberrant FOXK2 expression impacts tumors. This review details FOXK2 gene expression, its diagnostic potential, and mechanisms of deregulation in cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- FOXK2 is a transcription factor regulating cell fate.
- Aberrant FOXK2 expression is observed in various tumors, impacting biology and clinical outcomes.
- Mechanisms of FOXK2 gene deregulation in cancer remain largely unknown.
Purpose of the Study:
- To systematically review FOXK2 gene expression across different tumor types.
- To discuss the potential of FOXK2 as a prognostic and diagnostic molecular marker.
- To explore emerging mechanisms of FOXK2 deregulation in cancer.
Main Methods:
- Systematic review of FOXK2 gene expression profiles in distinct tumor types.
- Analysis of genetic and transcriptional modifications contributing to FOXK2 deregulation.
Main Results:
- FOXK2 exhibits altered expression patterns in various cancers.
- FOXK2 shows potential as a diagnostic and prognostic marker.
- Mechanisms including gene methylation, mutation, and copy number variations contribute to FOXK2 deregulation.
Conclusions:
- Understanding FOXK2 deregulation is crucial for cancer research.
- FOXK2 holds promise as a biomarker for cancer diagnosis and prognosis.
- Further investigation into FOXK2's role can inform therapeutic strategies.
More Related Videos
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
mTOR Signaling and Cancer Progression
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

